KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Debt Ratio (2016 - 2026)

Biocryst Pharmaceuticals filings provide 15 years of Debt Ratio readings, the most recent being 0.07 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 89.45% to 0.07 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07, a 89.45% decrease, with the full-year FY2025 number at 0.07, down 89.45% from a year prior.
  • Debt Ratio hit 0.07 in Q4 2025 for Biocryst Pharmaceuticals, down from 0.52 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.73 in Q1 2025 to a low of 0.07 in Q4 2025.
  • Median Debt Ratio over the past 5 years was 0.51 (2021), compared with a mean of 0.5.
  • Biggest five-year swings in Debt Ratio: soared 95.46% in 2023 and later crashed 89.45% in 2025.
  • Biocryst Pharmaceuticals' Debt Ratio stood at 0.23 in 2021, then surged by 82.02% to 0.42 in 2022, then soared by 50.11% to 0.63 in 2023, then increased by 12.1% to 0.71 in 2024, then crashed by 89.45% to 0.07 in 2025.
  • The last three reported values for Debt Ratio were 0.07 (Q4 2025), 0.52 (Q3 2025), and 0.61 (Q2 2025) per Business Quant data.